Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Ani Pharmaceuticals (ANIP) Return on Invested Capital (2016 - 2025)

Historic Return on Invested Capital for Ani Pharmaceuticals (ANIP) over the last 14 years, with Q3 2025 value amounting to 0.07%.

  • Ani Pharmaceuticals' Return on Invested Capital rose 600.0% to 0.07% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.07%, marking a year-over-year increase of 600.0%. This contributed to the annual value of 0.0% for FY2024, which is 600.0% down from last year.
  • Ani Pharmaceuticals' Return on Invested Capital amounted to 0.07% in Q3 2025, which was up 600.0% from 0.01% recorded in Q2 2025.
  • Ani Pharmaceuticals' Return on Invested Capital's 5-year high stood at 0.07% during Q3 2025, with a 5-year trough of 0.07% in Q1 2022.
  • Over the past 5 years, Ani Pharmaceuticals' median Return on Invested Capital value was 0.0% (recorded in 2024), while the average stood at 0.0%.
  • In the last 5 years, Ani Pharmaceuticals' Return on Invested Capital tumbled by -600bps in 2022 and then surged by 1300bps in 2023.
  • Over the past 5 years, Ani Pharmaceuticals' Return on Invested Capital (Quarter) stood at 0.06% in 2021, then surged by 37bps to 0.04% in 2022, then surged by 250bps to 0.06% in 2023, then crashed by -99bps to 0.0% in 2024, then surged by 11627bps to 0.07% in 2025.
  • Its last three reported values are 0.07% in Q3 2025, 0.01% for Q2 2025, and 0.01% during Q1 2025.